SDZXF:OTCMKTS
Sandoz Group AG
82,08Â US$
arrow_upward
+0,93%(+0,76) 1D
11 sht, 4:00:00 m.d., GMT-4 · USD
search
Të gjitha simbolet
1D
5D
1M
6M
YTD
1V
5V
Maks
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për SDZXF...
Hap
82,08Â US$
I lartë
82,08Â US$
I ulët
82,08Â US$
Kapitalizimi i tregut
29,51Â mld
Vëllimi mesatar
42,00
Vëllimi
0,00
Maksimumi 52-javor
94,55Â US$
Minimumi 52-javor
55,50Â US$
Aksionet në qarkullim
440,00Â mln
Numri i punonjësve
20 mijë
Hap
82,08Â US$
I lartë
82,08Â US$
I ulët
82,08Â US$
Kapitalizimi i tregut
29,51Â mld
Vëllimi mesatar
42,00
Vëllimi
0,00
Maksimumi 52-javor
94,55Â US$
Minimumi 52-javor
55,50Â US$
Aksionet në qarkullim
440,00Â mln
Numri i punonjësve
20 mijë
Profili
Sandoz Group AG is a Swiss company that focuses on generic pharmaceuticals and biosimilars. Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the name Sandoz. Before this, the company existed as an independent pharmaceutical manufacturer until 1996, when it was merged with Ciba-Geigy to form Novartis. Prior to the merger, it specialized in medicines used in organ transplants, such as Sandimmune, and various antipsychotics and migraine medicines. Its headquarters were in Holzkirchen, Germany and after the spin-off from Novartis, the headquarters moved to Basel, Switzerland, with most of global functions operating from Holzkirchen in Germany, Prague in Czechia, and Barcelona in Spain. Sandoz is the global leader in generic pharmaceuticals and biosimilars. Wikipedia
Rreth Sandoz Group AG
Drejtori ekzekutivRichard Saynor
Punonjësit20 mijë
Themeluar më1886
Selia-
Sektori-
Uebsajtisandoz.com